Saumbon, Arabella .

HRN: 27-13-78  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2025
CEFTRIAXONE 1G (VIAL)
05/18/2025
05/25/2025
IV
950mg
OD
AGE With Severe Dehydration
Waiting Final Action 
05/20/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/20/2025
05/27/2025
IV
70mg
Q8
Sepsis
Waiting Final Action 
05/20/2025
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
05/20/2025
05/27/2025
IV
56mg
OD
T/c CNS Fungal Infection
Waiting Final Action 
05/20/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/20/2025
05/27/2025
IV
138mg
OD
Sepsis
Waiting Final Action 
05/21/2025
MUPIROCIN 2%, 15G (TUBE)
05/21/2025
05/27/2025
TOPICAL
15
BID
Punctured Wound
Waiting Final Action 
05/25/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/25/2025
05/31/2025
IV
700 Mg
Q6H
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: